In December last year, Finance Minister Nirmala Sitharaman hailed India as the "Pharmacy of the World", owing to its high and efficient production of "global standard medicine" at affordable costs. However, that image suffered considerable damage following allegations of sub-standard or contaminated drugs exported to countries like Gambia and Uzbekistan.
To "ensure that the regulatory mechanisms of the country are of impeccable standards and are sustained over time and space", the Centre has begun a series of chintan shivirs or thought meets with the country's top drug regulators, senior government policy officials, industry representatives, and stakeholders to deliberate on pathways for cohesive and synergistic approaches for building robust and resilient regulatory systems.
Proposals to be discussed at the Hyderabad conclave include having a centralised drug registration system under the Central Drugs Standard Control Organisation (CDSCO) to keep close tabs on the quality of drugs produced.
Union Health Minister Mansukh Mandaviya inaugurated the two day chintan shivir on Drugs: Quality Regulations & Enforcement organised by the Ministry of Health in Hyderabad on Sunday.
This story is from the February 27, 2023 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 27, 2023 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
FY24 credit card spends rose 27%
Increased to ₹18.26 trillion from nearly ₹14 trillion a year ago
DCB Bank Q4 profit rises 9%
Private lender DCB Bank's net profit rose by 9 per cent year-on-year (Y-o-Y) to 156 crore for the quarter ended March (Q4FY24) on the back of a modest rise in net interest income (NII) and a decline in provisions.
Axis Bank back in black with ₹7,129 cr Q4 profit
NII grew 11% to ₹13,089 cr, while fee income grew by 23% to ₹5,637 cr
Growth businesses hold the key for Tata Consumer
Tata Consumer Products reported Q4 results which were more or less in line with analyst consensus but disappointed the market.
Financialisation of savings drives up demat a/cs in Ladakh
Mizoram & Lakshadweep also see spike in demat account registrations
KRAS: Over 73% of KYC records are validated
Know-your-customer (KYC) registration agencies said on Wednesday that 73 per cent of the 108.3 million KYC records were validated as of March 31, 2024, and that the system was in place for the rest of the investors to validate their KYC.
Proxy advisory firms give TaMo DVR conversion plan the thumbs up
Move, they say, will simplify capital structure and eliminate price discount
Call for caution on micro, small, midcap stocks amid sharp run-up
Shares of smallcap companies continued their upward march from the March 2024 lows, with the S&P BSE Smallcap index hitting a new high of ₹46,958.21 on Wednesday in intraday trade.
Calcutta HC's SSC order heats up the election classroom
Political analysts believe cancelling of 25,753 appointments will have serious ramifications
Wanted: An executive to repair Boeing
When Boeing named Stephanie Pope to the new position of chief operating officer in December, the move was widely viewed as a sign that she might succeed the company's chief executive, Dave Calhoun, in the next few years.
